NAVIDEA BIOPHARMACEUTICALS I's ticker is and the CUSIP is 63937X952. A total of 2 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $52,000 | -76.1% | 206,900 | -31.6% | 0.00% | – |
| Q2 2022 | $218,000 | -4.8% | 302,500 | +4.6% | 0.00% | – |
| Q1 2022 | $229,000 | -13.6% | 289,300 | +9.2% | 0.00% | – |
| Q4 2021 | $265,000 | +211.8% | 265,000 | +447.5% | 0.00% | – |
| Q3 2021 | $85,000 | +39.3% | 48,400 | +46.2% | 0.00% | – |
| Q2 2021 | $61,000 | 0.0% | 33,100 | +8.9% | 0.00% | – |
| Q1 2021 | $61,000 | -20.8% | 30,400 | -15.3% | 0.00% | – |
| Q4 2020 | $77,000 | -18.9% | 35,900 | +2.6% | 0.00% | – |
| Q3 2020 | $95,000 | +533.3% | 35,000 | +797.4% | 0.00% | – |
| Q2 2020 | $15,000 | +400.0% | 3,900 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -95.6% | 3,900 | -92.8% | 0.00% | – |
| Q4 2019 | $68,000 | +94.3% | 53,900 | +7.8% | 0.00% | – |
| Q3 2019 | $35,000 | +483.3% | 50,000 | +400.0% | 0.00% | – |
| Q2 2019 | $6,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 35,900 | $77,000 | 0.00% |
| SIMPLEX TRADING, LLC | 170 | $36,000 | 0.00% |